Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS) ar
e severe life-threatening dermatologic conditions. To date, eight case
s of TEN and one of SJS related to lamotrigine administration have bee
n reported in the literature. Most patients were also taking concomita
nt valproic acid. It was hypothesized that valproic acid may interfere
with glucuronidation of lamotrigine, leading to increased serum lamot
rigine levels, or perhaps alter the drug's metabolism, resulting in ac
cumulation of a toxic intermediate metabolite. Ultimately, this may po
ssibly predispose a patient to increased dermatologic reactions, inclu
ding TEN. A 54-year-old man developed TEN 4 weeks after beginning lamo
trigine for complex partial seizures related to a glioblastoma multifo
rme brain tumor. The patient had also been taking concomitant allopuri
nol and captopril for more than 4 years with no complications, and val
proic acid 3 months before the cutaneous event. Despite aggressive int
ensive care management, the patient died 17 days from the onset of sym
ptoms due to multiple organ failure. Administration of lamotrigine, es
pecially in combination with valproic acid, may lead to the developmen
t of TEN.